Ronish Bioceuticals presents a strong business opportunity in the Indian pharmaceutical sector with its popular syrup formulation – NISHKUF LS. This medicine contains LEVOSALBUTAMOL 1MG + AMBROXOL HYDROCHLORIDE 30MG + GUAIPHENESIN 50MG/5ML, which is used for treating respiratory tract infections, cough, and bronchitis.
The combination of levosalbutamol sulphate ambroxol hydrochloride and guaiphenesin is trusted by doctors for treating wet cough and improving breathing comfort. Offering this product under a franchise model can help wholesalers, doctors, and medical representatives grow their business in the pharmaceutical field.
NISHKUF LS is a liquid expectorant used to relieve productive cough, throat irritation, and chest congestion. It combines three active ingredients:
This combination helps improve lung function and provides relief in conditions like asthma, bronchitis, and chronic obstructive pulmonary disease (COPD).
NISHKUF LS is commonly prescribed during flu, seasonal infections, or upper respiratory tract infections for effective mucus clearance.
The combination of ambroxol hydrochloride 30mg levosalbutamol 1mg & guaiphenesin 50mg syrup is often recommended by pediatricians and general physicians for managing respiratory symptoms effectively.
Respiratory tract infections are common in India, especially during the monsoon and winter seasons. The rising cases of cough, cold, and pollution-related breathing issues have increased the demand for medicines like levosalbutamol ambroxol hydrochloride guaiphenesin syrup.
This market demand creates a steady business opportunity for those looking to start or expand their pharmaceutical business. Doctors frequently prescribe ambroxol hydrochloride guaiphenesin & levosalbutamol sulphate syrup, which helps in building a consistent supply-demand cycle.
Ronish Bioceuticals offers a pharma franchise opportunity for this high-demand medicine – NISHKUF LS. Interested parties can join as distributors, wholesalers, or medical representatives to promote this syrup across cities, districts, or states.
By joining hands with Ronish Bioceuticals, one can start with a low investment and gain high returns from consistent product sales.
Along with the pharma franchise, Ronish Bioceuticals also offers third-party manufacturing services for healthcare products. If you want to launch your brand of levosalbutamol ambroxol hydrochloride and guaiphenesin syrup, you can partner with us for quality production under your label.
Our facilities follow proper hygiene, quality assurance, and production guidelines to ensure the safety and effectiveness of each batch.
With increasing demand for ambroxol hydrochloride levosalbutamol sulphate and guaiphenesin, the opportunity to grow in this therapeutic segment is strong.
This model works best for those who want regular income from a growing medicine line. Products like levosalbutamol ambroxol hydrochloride and guaiphenesin have regular prescriptions, especially during seasonal flu or pollution spikes.
NISHKUF LS comes in attractive syrup bottles with complete labelling. The information includes composition, dosage, expiry, MRP, manufacturing details, and safety instructions.
Each batch of ambroxol hydrochloride 30mg levosalbutamol 1mg guaiphenesin 50mg syrup goes through strict quality control before delivery.
NISHKUF LS helps relieve cough, loosen mucus, and clear airways. It makes breathing easier in cold, cough, and chest congestion.
If you are looking for a reliable business model in the pharmaceutical industry, partnering with Ronish Bioceuticals for NISHKUF LS can be a good decision. The consistent demand for levosalbutamol sulphate ambroxol hydrochloride and guaiphenesin syrup and quality support from the company ensures business growth.
We offer the PCD Pharma Franchise for wholesalers, Doctors, and MRs. You can start with Ronish Bioceuticals and build your pharma career with the Best PCD Pharma Company.
NISHKUF LS is used to treat wet cough, bronchitis, and chest congestion. It helps clear mucus and improve breathing.
Take the syrup as prescribed by the doctor. Generally, it is taken 2-3 times daily after meals. Shake well before use.
Yes, but only under pediatric supervision. Dosage should be based on the child’s age and condition.
Some common side effects may include nausea, dry mouth, or dizziness. Always follow the prescribed dose.
Yes. Ronish Bioceuticals offers a franchise for NISHKUF LS and other products. You can contact them to get monopoly rights and start your business.